Amit Akirov, MD, Author at Ophthalmology Advisor

Fluid Therapy Following Traumatic Brain Injury

By

Amit Akirov, MD

August 30, 2021

Study researchers evaluated the differences in fluid management in patients with traumatic brain injury in the intensive care unit.

General Medicine

Anakinra Reduces Need for Mechanical Ventilation and Mortality Risk in Hospitalized Nonintubated Patients With COVID-19

By

Amit Akirov, MD

August 16, 2021

In this meta-analysis, study authors showed that treatment with anakinra reduced the need for invasive mechanical ventilation and mortality risk in hospitalized nonintubated patients with COVID-19.

Neuro-ophthalmology

Carotid Web Increases Recurrent Stroke Risk

By

Amit Akirov, MD

August 3, 2021

A team of investigators evaluated the 2-year recurrent stroke risk in patients with symptomatic carotid web.

Neuro-ophthalmology

Impact of Alemtuzumab on the Visual System in Patients with Multiple Sclerosis

By

Amit Akirov, MD

July 27, 2021

Study investigators used the visual pathway to assess the promyelinating and neuroprotective effects of alemtuzumab in multiple sclerosis.

Neuro-ophthalmology

Osmophobia May Be a Clinical Diagnostic Marker of Pediatric Migraine

By

Amit Akirov, MD

July 22, 2021

Study researchers evaluated the potential of osmophobia in as a clinical diagnostic marker of migraine in children and adolescents.

Neuro-ophthalmology

Neurologic and Psychiatric Symptoms Common in COVID-19 Survivors

By

Amit Akirov, MD

July 19, 2021

Researchers strove to provide robust estimates of incidence rates and relative risks of neurologic and psychiatric diagnoses in patients in the 6 months following a COVID-19 diagnosis.

Neuro-ophthalmology

The Effects of ICD Coding Transition on Neurologic Diagnoses

By

Amit Akirov, MD

May 17, 2021

The transition from the International Classification of Disease (ICD)-9 to ICD-10 coding system may impact estimates of neurologic disease prevalence.

Temporal arteritis, light micrograph of a section of an affected vessel.

Neuro-ophthalmology

Investigators Study Long-Term Efficacy and Safety of Tocilizumab in Patients With Giant Cell Arteritis

By

Amit Akirov, MD

May 4, 2021

In an open-label study of the GiACTA trial, investigators studied the long-term effect of tocilizumab in patients with giant cell arteritis.

Retina & Vitreous

Assessing Quality of Life, Mental Health in Children With Juvenile Idiopathic Arthritis and Uveitis

By

Amit Akirov, MD

March 5, 2021

Researchers assessed quality of life, mental health, physical disability, and vision-related functioning in children with juvenile idiopathic arthritis and noninfectious uveitis.

General Ophthalmology

Perioperative Use of Gabapentinoids Reveals No Clinically Significant Analgesic Effect

By

Amit Akirov, MD

October 1, 2020

Pregabalin/gabapentin observed for clinically meaningfully advantages in the management of postoperative pain in adults.

Amit Akirov, MD

All articles by Amit Akirov, MD

Fluid Therapy Following Traumatic Brain Injury

Anakinra Reduces Need for Mechanical Ventilation and Mortality Risk in Hospitalized Nonintubated Patients With COVID-19

Carotid Web Increases Recurrent Stroke Risk

Impact of Alemtuzumab on the Visual System in Patients with Multiple Sclerosis

Osmophobia May Be a Clinical Diagnostic Marker of Pediatric Migraine

Neurologic and Psychiatric Symptoms Common in COVID-19 Survivors

The Effects of ICD Coding Transition on Neurologic Diagnoses

Investigators Study Long-Term Efficacy and Safety of Tocilizumab in Patients With Giant Cell Arteritis

Assessing Quality of Life, Mental Health in Children With Juvenile Idiopathic Arthritis and Uveitis

Perioperative Use of Gabapentinoids Reveals No Clinically Significant Analgesic Effect

Guidelines for Care of Adults With Steven-Johnson Syndrome, Toxic Epidermal Necrolysis